RecruitingPhase IIEN originalKidney cancer

Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

The goal of this prospective, single-arm feasibility study is to evaluate the safety and feasibility of using Gleolan® (5-aminolevulinic acid), an FDA-approved drug currently used during brain tumor surgery, in adults with suspected kidney cancer undergoing partial nephrectomy. Gleolan has shown promise in improving the visualization of cancerous tissue, and this study aims to assess its potential use in urologic oncology. The main questions it aims to answer are: * Is Gleolan safe and well tolerated in patients with suspected kidney cancer undergoing partial nephrectomy? * Is the use of Gleolan feasible for fluorescence-guided identification of kidney cancer lesions during surgery? Participants will: * Receive Gleolan before surgery according to the study protocol. * Undergo partial nephrectomy, during which fluorescence imaging will be used to evaluate the visualization of kidney tumor tissue. * Be monitored for safety outcomes and any adverse events before, during, and after surgery.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • •Wiek co najmniej 18 lat
  • •Lekarz zalecił częściowe usunięcie nerki
  • •Możliwość wyrażenia świadomej zgody na badanie
  • •Możliwość wypełnienia wymagań badania

✗ Disqualifies

  • •Porfiria (zaburzenie krwi) lub uczulenie na substancje z grupy porfiryn
  • •Ciąża lub karmienie piersią
  • •Zaburzenia czynności wątroby (AST lub ALT powyżej 2-krotności normy)
  • •Uczestnictwo w innym badaniu w ostatnich 30 dniach
  • •Alergia na lek 5-ALA (Gleolan) lub jego składniki

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Maximum age
75 Years
Last updated (source)
September 18, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (1)

Henry Ford Health

Detroit, United States

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/19/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.